---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-211859"
form_type: "8-K"
ticker: "VIR"
cik: "0001706431"
company_name: "Vir Biotechnology, Inc."
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T04:16:45.112734+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Vir Biotechnology delays Q2 2022 earnings release to Aug 9, 2022 to finalize results

## Summary
- Company will issue Q2 2022 earnings release on August 9, 2022 after market close.
- Delay allows additional time to finalize financial results for the quarter ended June 30, 2022.
- Quarterly Report on Form 10-Q remains scheduled for filing on or before its due date of August 9, 2022.

## SEC filing metadata
- accession: 0001193125-22-211859
- form_type: 8-K
- ticker: VIR
- cik: 0001706431
- company_name: Vir Biotechnology, Inc.
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1706431/000119312522211859/0001193125-22-211859-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1706431/000119312522211859/d389021d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-211859
- JSON: https://secwatch.observer/filing/0001193125-22-211859.json
- Plain text: https://secwatch.observer/filing/0001193125-22-211859.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.